Pemirolast: Difference between revisions
Created page with "{{Drugbox | Verifiedfields = changed | verifiedrevid = 408530718 | IUPAC_name = 9-methyl-3-(1''H''-tetrazol-5-yl)-4''H''-pyrido[1,2-''a'']pyrimidin-4-one | image = Pemirolast...." |
m Protected "Pemirolast": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 32: | Line 32: | ||
| ATC_supplemental = | | ATC_supplemental = | ||
| PubChem = 57697 | | PubChem = 57697 | ||
| DrugBank_Ref = {{drugbankcite| | | DrugBank_Ref = {{drugbankcite|changed|drugbank}} | ||
| DrugBank = | | DrugBank = DB00885 | ||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ||
| ChemSpiderID = 51990 | | ChemSpiderID = 51990 | ||
Line 49: | Line 49: | ||
| smiles = CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3 | | smiles = CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3 | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | ==Overview== | ||
'''Pemirolast''' ([[International Nonproprietary Name|INN]]) is a [[mast cell stabilizer]] used as an anti-allergic drug therapy. It is marketed under the tradenames '''Alegysal''' and '''Alamast'''. | |||
'''Pemirolast''' ([[International Nonproprietary Name|INN]]) is an anti-allergic drug. It is marketed under the tradenames '''Alegysal''' and '''Alamast'''. | |||
It has also been studied for the treatment of asthma. | It has also been studied for the treatment of asthma. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:H1 receptor antagonists]] | [[Category:H1 receptor antagonists]] | ||
[[Category:Tetrazoles]] | [[Category:Tetrazoles]] | ||
[[Category:Lactams]] | [[Category:Lactams]] | ||
[[Category: | [[Category:Drug]] | ||
Latest revision as of 16:54, 20 August 2015
Clinical data | |
---|---|
Trade names | Alamast |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
Routes of administration | Oral, ophthalmic |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C10H8N6O |
Molar mass | 228.21 g/mol |
3D model (JSmol) | |
| |
(what is this?) (verify) |
WikiDoc Resources for Pemirolast |
Articles |
---|
Most recent articles on Pemirolast |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Pemirolast at Clinical Trials.gov Clinical Trials on Pemirolast at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Pemirolast
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Pemirolast Discussion groups on Pemirolast Patient Handouts on Pemirolast Directions to Hospitals Treating Pemirolast Risk calculators and risk factors for Pemirolast
|
Healthcare Provider Resources |
Causes & Risk Factors for Pemirolast |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pemirolast (INN) is a mast cell stabilizer used as an anti-allergic drug therapy. It is marketed under the tradenames Alegysal and Alamast.
It has also been studied for the treatment of asthma.
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Drugs not assigned an ATC code
- Drugs with non-standard legal status
- Articles with changed DrugBank identifier
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without InChI source
- Drugboxes which contain changes to verified fields
- H1 receptor antagonists
- Tetrazoles
- Lactams
- Drug